[email protected]

01252 375362

01252 375362

  • About Us
    • About Pharmacy Consulting
    • Our Team
    • Work with us
    • Testimonials
  • Consultancy
    • For Pharmaceutical Wholesalers
    • For Pharmacies
    • Care Quality Commission – CQC
    • Pharmaceutical Manufacturers
    • Medical Devices Consultancy and Training
  • Flexible Training
    • Good Distribution Practice (GDP) Training
    • RPi Training
    • Licence Holder Training
    • Export Training
    • Audit Training
    • Active Pharmaceutical Ingredient (API) and Clinical Trials Training
    • Superintendent Pharmacist Training
    • GPhC Guidance for Online Pharmacies
  • RP Cogent GDP Training
  • RP Forum
  • Training Calendar
  • Our CPD
    • Blog
    • Editorial Items
    • Social Media
  • Contact Us
Who is responsible when the “Serious Shortage Protocol” is put into action and will you be insured?

Who is responsible when the “Serious Shortage Protocol” is put into action and will you be insured?

by Jackie (née Heneghan) Peck | Mar 18, 2019 | Blog

If a pharmacy allows the pharmacist to supply different strengths, quality or pharmaceutical form or indeed a different medicine to the prescription only medicine prescribed, using the newly agreed “Serious Shortage Protocol” who is liable if the patient...

Travel insurance after Brexit have you considered buying?

by Jackie (née Heneghan) Peck | Mar 18, 2019 | Blog

The Government is advising people that they must obtain their own travel insurance after Brexit. This is because the European Health Insurance Card the EHIC will disappear over night. This will also affect all the UK citizens who currently live abroad and take up...

How will the reclassification of pregabalin affect the supply chain

by Jackie (née Heneghan) Peck | Mar 18, 2019 | Blog

From the 1st of  April 2019 pregabalin and gabapentin will be re-classified as class C controlled substances in the UK. The change has been prompted due to a sharp increase in deaths which toxicology has proved an association with the medicines. In addition the...

Keeping up with Brexit

by Jackie (née Heneghan) Peck | Mar 12, 2019 | Blog

brexit fmd WDA(H) Responsible Person

Medical Research wastage due to ethical , scientific and economic deficiencies is scandalous.

by Jackie (née Heneghan) Peck | Jan 2, 2019 | Behind the scenes, Blog, Pharmacy Brands

In this day and age we would hope that medical research and clinical trials would be tightly controlled and effective.  In 1994, Altman stated  that we should be appalled at the money wasted in shoddy medical research  where the sample size was too small to be...
« Older Entries
Next Entries »

Recent Posts

  • What are the main requirements for controlled drugs?
  • FSN for Zoll Powerheart G5 AEDs
  • Virtual Wholesaling

Upcoming Courses

  • RP Forum – Inspection Preparation and RP Readiness on 8 July 2025 10:00 am
  • GDP/RP Cogent Gold Standard Online Training on 15 July 2025
  • GDP Audit Online Training on 17 July 2025 10:00 am
  • Introduction to Good Distribution Practice Online Training on 23 July 2025 10:00 am
  • Export Online Training on 7 August 2025

MHRA Alerts & Recalls

Field Safety Notices: 9 to 13 June 2025
17 June 2025
MHRA Safety Roundup: May 2025
13 June 2025
Class 2 Medicines Recall: Inhixa 12,000IU (120mg)/0.8mL solution for injection, Maxearn Limited, EL(25)A/27
12 June 2025
Class 4 Medicines Defect Notification: Dulcolax Adult 5 mg Gastro-resistant Tablets, Opella Healthcare UK, EL(25)A/26
10 June 2025

Get In Touch

Address:
Wellesley House
10 Eelmoor Road
Farnborough
Hampshire
GU14 7QN

Phone: 01252 375362
Email: [email protected]
  • Terms and Conditions
  • Privacy Policy

Designed by Four Lakes

  • Follow
  • Follow
  • Follow
  • Follow